XML 32 R22.htm IDEA: XBRL DOCUMENT v3.25.0.1
Restatement of Previously Issued Financial Statements (Tables)
9 Months Ended
Sep. 30, 2024
Accounting Changes and Error Corrections [Abstract]  
Schedule of Error Corrections and Prior Period Adjustments
The impact of the restatement on the consolidated balance sheet as of September 30, 2024 is as follows (in thousands):
September 30, 2024
(unaudited)
Assets
Accounts receivable 10,205 15,667 25,872 
Prepaid expenses and other current assets20,146 602 20,748 
Total current assets 573,328 16,269 589,597 
Total assets $983,635 $16,269 $999,904 
Liabilities and stockholders’ equity
Current liabilities
Deferred income37,865 (37,865)— 
Debt7,749 36,706 44,455 
Total current liabilities 91,972 (1,159)90,813 
Uncertain tax position payable— 8,336 8,336 
Deferred income, net of current portion94,107 (94,107)— 
Debt, net of current portion10,169 118,171 128,340 
Total liabilities 262,737 31,241 293,978 
Stockholders’ equity
Accumulated deficit (643,511)(14,972)(658,483)
Total stockholders’ equity 720,898 (14,972)705,926 
Total liabilities and stockholders’ equity $983,635 $16,269 $999,904 
The impact of the restatement on the consolidated statements of loss for the three months ended September 30, 2024 is as follows (in thousands):
Three Months Ended September 30, 2024
As ReportedAdjustmentAs Restated
Revenue
Collaborations, milestones, and royalties$10,710 $7,086 $17,796 
Loss from operations(62,283)7,086 (55,197)
Other income (expense)
Interest expense
(795)(8,231)(9,026)
Loss before income tax expense(46,297)(1,145)(47,442)
Income tax expense— — — 
Net loss(46,297)(1,145)(47,442)
Net loss attributable to non-controlling interest(1,154)— (1,154)
Net loss attributable to Xencor, Inc.(45,143)(1,145)(46,288)
Basic and diluted net loss per common share attributable to Xencor, Inc.$(0.71)$(0.01)$(0.72)
The impact of the restatement on the consolidated statement of loss for the nine months ended September 30, 2024 is as follows (in thousands):
Nine Months Ended September 30, 2024
As ReportedAdjustmentAs Restated
Revenue
Collaborations, milestones, and royalties$40,475 $17,225 $57,700 
Loss from operations(182,455)17,225 (165,230)
Other income (expense)
Interest expense(2,716)(25,268)(27,984)
Loss before income tax expense(182,297)(8,043)(190,340)
Income tax expense117 (117)— 
Net loss(182,414)(7,926)(190,340)
Net loss attributable to non-controlling interest(3,275)— (3,275)
Net loss attributable to Xencor, Inc.$(179,139)$(7,926)$(187,065)
Basic and diluted net loss per common share attributable to Xencor, Inc.$(2.87)$(0.13)$(3.00)
The impact of the restatement on the consolidated statements of comprehensive loss for the three months ended September 30, 2024 is as follows (in thousands):
Three Months Ended September 30, 2024
As ReportedAdjustmentAs Restated
Net loss(46,297)(1,145)(47,442)
Other comprehensive income
Net unrealized gain on marketable debt securities 2,452 — 2,452 
Comprehensive loss(43,845)(1,145)(44,990)
Comprehensive loss attributable to non-controlling interest(1,154)— (1,154)
Comprehensive loss attributable to Xencor, Inc.$(42,691)$(1,145)$(43,836)
The impact of the restatement on the consolidated statement of comprehensive loss for the nine months ended September 30, 2024 is as follows (in thousands):
Nine Months Ended September 30, 2024
As ReportedAdjustmentAs Restated
Net loss(182,414)(7,926)(190,340)
Other comprehensive income
Net unrealized gain on marketable debt securities510 — 510 
Comprehensive loss(181,904)(7,926)(189,830)
Comprehensive loss attributable to non-controlling interest(3,275)— (3,275)
Comprehensive loss attributable to Xencor, Inc.$(178,629)$(7,926)$(186,555)
The impact of the restatement on the consolidated statements of cash flows for the nine months ended September 30, 2024 is as follows (in thousands):
Nine Months Ended September 30, 2024
As ReportedAdjustmentAs Restated
Cash flows from operating activities
Net loss$(182,414)$(7,926)$(190,340)
Adjustments to reconcile net loss to net cash used in operating activities:
Non-cash royalty revenue related to sale of future royalties— (48,646)(48,646)
Non-cash interest expense2,682 25,268 27,950 
Changes in operating assets and liabilities:
Accounts receivable1,085 790 1,875 
Income taxes(5,782)(117)(5,899)
Deferred income(24,893)24,893 — 
Net cash used in operating activities (146,613)(5,738)(152,351)
Cash flows from financing activities
Reduction of liability for sale of future royalties(5,738)5,738 — 
Net cash provided by financing activities 186,983 5,738 192,721